Advertisement

Third-trimester repeat HIV testing: it is time we make it universal

Published:April 28, 2021DOI:https://doi.org/10.1016/j.ajog.2021.04.250
      Since the 1990s, perinatal transmission of HIV has decreased substantially, largely as a result of improved detection secondary to routine HIV screening in pregnancy and the use of antiretroviral therapy. However, despite reductions in HIV transmission, elimination of perinatal transmission, defined as an incidence of perinatal HIV infection of <1 per 100,000 live births and a transmission rate of <1%, remains elusive. An estimated 80% of perinatal transmissions occur after 36 weeks’ gestation, which highlights the importance of diagnosis and treatment of maternal HIV infection before the highest-risk period for perinatal transmission. With timely identification of seroconversion, intrapartum and neonatal interventions can lower the risk of perinatal transmission from 25% to 10%, substantially reducing perinatal transmission events. The American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention recommend that routine HIV testing be performed in all pregnancies, as early in the prenatal course as possible. Third-trimester repeat testing is only recommended for individuals known to be at high risk of acquiring HIV (ie, those who are incarcerated; who reside in jurisdictions with elevated HIV incidence; who are receiving care in facilities that have an HIV incidence in pregnant women > 1 per 1000 per year; or have signs or symptoms of acute HIV). However, among reproductive-age women, heterosexual intercourse is the most common mode of HIV transmission, and the risk of HIV seroconversion is greater during pregnancy than outside of pregnancy. Furthermore, state statutes for HIV testing in pregnancy are largely lacking. In this clinical opinion, we reviewed the evidence in support of universal third-trimester repeat HIV testing in pregnancy using a successful state-mandated testing program in Illinois. In addition, we provided clinical recommendations to further reduce missed perinatal transmission cases by implementing universal third-trimester repeat testing, obtaining hospital buy-in, monitoring testing adherence, bridging communications across multidisciplinary teams, and engaging clinicians in advocacy work.

      Key words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Centers for Disease Control and Prevention
        Diagnoses of HIV infection in the United States and dependent areas, 2018.
        (Available at:) (Accessed September 1, 2020)
        • Centers for Disease Control and Prevention
        HIV and women.
        (Available at:) (Accessed December 1, 2020)
        • Mofenson L.M.
        Protecting the next generation—eliminating perinatal HIV-1 infection.
        N Engl J Med. 2010; 362: 2316-2318
        • European Mode of Delivery Collaboration
        Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.
        Lancet. 1999; 353: 1035-1039
        • Connor E.M.
        • Sperling R.S.
        • Gelber R.
        • et al.
        Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
        N Engl J Med. 1994; 331: 1173-1180
        • Birkhead G.S.
        • Pulver W.P.
        • Warren B.L.
        • Hackel S.
        • Rodríguez D.
        • Smith L.
        Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006.
        Obstet Gynecol. 2010; 115: 1247-1255
        • Kourtis A.P.
        • Bulterys M.
        • Nesheim S.R.
        • Lee F.K.
        Understanding the timing of HIV transmission from mother to infant.
        JAMA. 2001; 285: 709-712
        • Wade N.A.
        • Birkhead G.S.
        • Warren B.L.
        • et al.
        Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
        N Engl J Med. 1998; 339: 1409-1414
        • Camacho-Gonzalez A.F.
        • Kingbo M.H.
        • Boylan A.
        • Eckard A.R.
        • Chahroudi A.
        • Chakraborty R.
        Missed opportunities for prevention of mother-to-child transmission in the United States.
        AIDS. 2015; 29: 1511-1515
      1. ACOG Committee Opinion no. 752 summary: prenatal and perinatal human immunodeficiency virus testing.
        Obstet Gynecol. 2018; 132: 805-806
        • World Health Organization
        Consolidated guidelines on HIV testing services.
        (Available at:) (Accessed December 1, 2020)
        • Centers for Disease Control and Prevention
        Perinatal HIV testing.
        (Available at:)
        https://www.cdc.gov/hiv/policies/law/states/perinatal.html
        Date: 2020
        Date accessed: November 2, 2020
      2. Perinatal HIV Prevention Act. Illinois Perinatal HIV Prevention Act. P.A. 100-0265, 2017
        • Centers for Disease Control and Prevention
        Selected national HIV prevention and care outcomes.
        (Available at:) (Accessed December 1, 2020)
      3. Singh A Lampe MA, Surendera Babu A, Rao S, Borkowf CB, et al. HIV seroconversion during pregnancy and mother-to-child HIV transmission: data from the Enhanced Perinatal Surveillance Project, United States, 2005–2010. Paper presented at: 19th International AIDS Conference; July 2012; Washington, DC.

        • Lockman S.
        • Creek T.
        Acute Maternal HIV Infection during Pregnancy and Breast-Feeding: Substantial Risk to Infants.
        The J Infect Dis. 2009; 200: 667-669
        • Fiebig E.W.
        • Wright D.J.
        • Rawal B.D.
        • et al.
        Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.
        AIDS. 2003; 17: 1871-1879
        • Robb M.L.
        • Eller L.A.
        • Kibuuka H.
        • et al.
        Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.
        N Engl J Med. 2016; 374: 2120-2130
        • Morrison C.S.
        • Demers K.
        • Kwok C.
        • et al.
        Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.
        AIDS. 2010; 24: 573-582
        • Garcia P.M.
        • Kalish L.A.
        • Pitt J.
        • et al.
        Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and infants Transmission Study Group.
        N Engl J Med. 1999; 341: 394-402
      4. Singh S. LM, Surendera B, S. R, Borkowf CB, Nesheim SR. HIV seroconversion during pregnancy and mother-to-child HIV transmission: data from the enhanced perinatal surveillance projects, United States, 2005–2010. Paper presented at: 20th Conference on Retroviruses and Opportunistic Infections (CROI); March 2013; Atlanta, GA.

        • Peters H.
        • Thorne C.
        • Tookey P.A.
        • Byrne L.
        National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt?.
        HIV Med. 2018; 19: 280-289
      5. Illinois Perinatal HIV Prevention Act. P.A. (2003). 93-566, amended by PA 94-0910 (2006), amended by P.L. 95-702 (2007).

        • Wong A.E.
        • Garcia P.M.
        • Olszewski Y.
        • et al.
        Perinatal HIV testing and diagnosis in Illinois after implementation of the Perinatal Rapid Testing Initiative.
        Am J Obstet Gynecol. 2012; 207: 401.e1-401.e6
        • AIDS Foundation of Chicago
        The Illinois perinatal HIV prevention law and 2006 Amendment.
        (Available at:) (Accessed September 1, 2020)
        • Yee L.M.
        • Miller E.S.
        • Statton A.
        • et al.
        Sustainability of statewide rapid HIV testing in labor and delivery.
        AIDS Behav. 2018; 22: 538-544
      6. Ayala L, Miller EM, Deardorff Carter S, et al. Repeat third trimester HIV testing: an opportunity to prevent maternal to child transmission. Paper presented at: 2015 American Public Health Association Annual Meeting and Expo; November 2015; Chicago, IL.

        • Ishikawa N.
        • Dalal S.
        • Johnson C.
        • et al.
        Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings.
        J Int AIDS Soc. 2016; 19: 21212
        • Sansom S.L.
        • Jamieson D.J.
        • Farnham P.G.
        • Bulterys M.
        • Fowler M.G.
        Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission.
        Obstet Gynecol. 2003; 102: 782-790
        • Scott R.K.
        • Crochet S.
        • Huang C.C.
        Universal rapid human immunodeficiency virus screening at delivery: a cost-effectiveness analysis.
        Infect Dis Obstet Gynecol. 2018; 2018: 6024698
        • Szlachta-McGinn A.
        • Aserlind A.
        • Duthely L.
        • et al.
        HIV screening during pregnancy in a U.S. HIV epicenter.
        Infect Dis Obstet Gynecol. 2020; 2020: 8196342
      7. The, Chapter 381. Public Health: General Provisions. The Florida Senate. In: 2011 Florida statutes. Title XXIX; 2016, vol. 2016.

        • Liao C.
        • Golden W.C.
        • Anderson J.R.
        • Coleman J.S.
        Missed opportunities for repeat HIV testing in pregnancy: implications for elimination of mother-to-child transmission in the United States.
        AIDS Patient Care STDs. 2017; 31: 20-26
        • Anderson J.E.
        • Koenig L.J.
        • Lampe M.A.
        • Wright R.
        • Leiss J.
        • Saul J.
        Achieving universal HIV screening in prenatal care in the United States: provider persistence pays off.
        AIDS Patient Care STDs. 2005; 19: 247-252
        • Anderson B.L.
        • Carlson R.
        • Anderson J.
        • Hawks D.
        • Schulkin J.
        What factors influence obstetrician-gynecologists to follow recommended HIV screening and testing guidelines?.
        J Womens Health (Larchmt). 2012; 21: 762-768
        • Boudova S.
        • Mark K.
        • El-Kamary S.S.
        Risk-based hepatitis C screening in pregnancy is less reliable than universal screening: a retrospective chart review.
        Open Forum Infect Dis. 2018; 5: ofy043
        • Porter K.
        • Wall P.G.
        • Evans B.G.
        Factors associated with lack of awareness of HIV infection before diagnosis of AIDS.
        BMJ. 1993; 307: 20-23
        • Waltz T.J.
        • Powell B.J.
        • Chinman M.J.
        • et al.
        Expert Recommendations for Implementing Change (ERIC): protocol for a mixed methods study.
        Implement Sci. 2014; 9: 39
        • Powell B.J.
        • Waltz T.J.
        • Chinman M.J.
        • et al.
        A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project.
        Implement Sci. 2015; 10: 21
        • Rucker M.G.
        • Eavou R.
        • Allgood K.L.
        • et al.
        Implementing routine HIV screening in three Chicago hospitals: lessons learned.
        Public Health Rep. 2016; 131: 121-129
        • Sanchez T.H.
        • Sullivan P.S.
        • Rothman R.E.
        • et al.
        A novel approach to realizing routine HIV screening and enhancing linkage to care in the United States: protocol of the FOCUS program and early results.
        JMIR Res Protoc. 2014; 3: e39
        • FitzHarris L.F.
        • Johnson C.H.
        • Nesheim S.R.
        • et al.
        Prenatal HIV testing and the impact of state HIV testing laws, 2004 to 2011.
        Sex Transm Dis. 2018; 45: 583-587
        • Nesheim S.
        • Harris L.F.
        • Lampe M.
        Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges.
        Curr Opin HIV AIDS. 2013; 8: 447-456